Global Cancer Cases Projected to Surge 60% by 2050, Urgent Action Needed

A recent study published in a leading medical journal forecasts that new cancer cases worldwide could increase by more than 60 percent over the next 25 years. The report highlights a worrying trend that predicts annual new cases will rise from 19 million in 2020 to 30.5 million by 2050, while cancer-related deaths are expected to escalate from 10.4 million to nearly 19 million each year.

The findings reveal that over half of the new cancer cases and two-thirds of cancer deaths will occur in low- and middle-income countries. Even in higher-income nations such as Canada, the number of new cancer cases and deaths is anticipated to continue growing, primarily due to aging populations and increased life expectancy. Despite these increases, cancer death rates have seen a decline in these regions, attributed largely to advancements in early diagnosis and treatment.

Over the past 25 years, cancer incidence rates have dropped by 9 percent per 100,000 individuals, while cancer mortality rates have decreased by 29 percent. Yet, the absolute numbers of cancer cases and deaths in countries like Canada have nearly doubled since 1990. This dual reality of declining rates but increasing case numbers poses significant challenges for healthcare systems.

The latest study aligns with findings from a World Health Organization report released in February of last year, which projected an even steeper rise in new cancer cases, estimating 35 million annually by 2050. These reports serve as a clarion call for action, prompting questions about whether governments are adequately preparing their healthcare systems for the impending surge.

In the province of Manitoba, concerns have been raised about the readiness of local health services to handle this looming crisis. More than a decade ago, healthcare professionals warned of an anticipated rise in cancer cases, yet many believe the system is less prepared now than it was then. In December 2022, Doctors Manitoba called for an independent investigation into CancerCare Manitoba after a review revealed a “high level of moral distress” among its physicians. The review indicated serious concerns that required urgent attention to address what many described as a toxic workplace culture.

Following this troubling report, Dr. Sri Navaratnam, CEO of CancerCare, announced her resignation. On the same day, she dismissed Jim Slater, the organization’s former chief of research administration and operations. Sources close to CancerCare suggested that his termination was perceived as a form of retaliation, creating further unease among staff.

The challenges faced by CancerCare are compounded by a global shortage of healthcare professionals, particularly oncologists. Attracting and retaining skilled cancer specialists will be critical as the agency prepares for the anticipated rise in cases. This task falls to Premier Wab Kinew and Health Minister Uzoma Asagwara, who have acknowledged the urgent need for reform.

There are signs of progress, however. In June 2023, Kinew announced the construction of a new CancerCare centre for research and treatment, with a budget of up to $1 billion, set to begin next year. Additionally, Dr. Kent Stobart has been appointed as the new CEO of CancerCare, a move that could help cultivate a more positive work environment within the agency.

While these developments are encouraging, experts assert that much more needs to be done to bolster the province’s healthcare infrastructure in anticipation of the cancer crisis ahead. The wellbeing of thousands of Manitobans is at stake, and immediate action is essential to ensure that adequate resources and support are in place. The clock is ticking, and the time for decisive measures is now.